Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-05-12 Purchase |
2022-05-16 08:32 am |
Nuvectis Pharma Inc. | NVCT | Kaplan Matthew L. Director |
3,000 | $16.88 | $50,633 | 35,760 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-06-13 Option Award |
2024-06-13 4:22 pm |
N/A N/A |
Nuvectis Pharma Inc. | NVCT | Kaplan Matthew L. Director |
30,000 | $0 | 83,760 (Direct) |
View |
| 2023-06-16 Option Award |
2023-06-20 08:16 am |
N/A N/A |
Nuvectis Pharma Inc. | NVCT | Kaplan Matthew L. Director |
18,000 | $0 | 53,760 (Direct) |
View |
| 2022-04-01 Option Award |
2022-04-05 4:48 pm |
2023-04-01 2032-04-01 |
Nuvectis Pharma Inc. | NVCT | Kaplan Matthew L. Director |
15,000 | $0 | 15,000 (Direct) |
View |
Ownership |
2022-02-08 08:32 am |
N/A N/A |
Nuvectis Pharma Inc. | NVCT | Kaplan Matthew L. Director |
0 | $0 | 62,010 (Direct) |
View |